Betaine in Patients With Nonalcoholic Steatohepatitis
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
To assess the safety and efficacy of betaine in patients with NASH on markers of disease
severity such as liver histology, liver biochemistries, and health related quality of life.